Hypophosphatemic nephrolithiasis/osteoporosis 2
MONDO:0012851Also known as: hypophosphatemic nephrolithiasis/osteoporosis type 2, nephrolithiasis/osteoporosis, hypophosphatemic, type 2, NPHLOP2, nephrolithiasis/osteoporosis, hypophosphatemic, 2
33 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New trial aims to slash deadly bloodstream infections from hospital tubes
Prevention Not yet recruitingThis study will test different methods to prevent infections and other problems from central lines (tubes placed in large veins) in 2,500 patients. It compares special antimicrobial caps and a skin anchor device against standard care. The goal is to find the best ways to keep pat…
Phase: NA • Sponsor: The University of Queensland • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
New study aims to find best pain relief for kids after kidney surgery
Symptom relief Not yet recruitingThis study compares two types of nerve blocks (ESPB and QLB) to see which provides better pain relief for children aged 2-12 after kidney surgery. One hundred children will be randomly assigned to receive one of the two blocks. The main goal is to see how long it takes before the…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Kidney function may change how D-2570 works in the body
Knowledge-focused Not yet recruitingThis study looks at how the drug D-2570 moves through the body in people with reduced kidney function compared to those with normal kidneys. About 40 adults aged 18 to 70 will receive a single dose of D-2570. Researchers will measure drug levels in the blood and monitor for side …
Phase: PHASE1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New kidney drug trial aims to find safe doses for patients
Knowledge-focused Not yet recruitingThis early-stage study tests a single injection of RG002C0106 in 24 adults to see how kidney function affects the drug's levels and safety. Participants have either normal kidneys or mild-to-moderate kidney impairment. The goal is to gather basic information, not to treat the dis…
Phase: PHASE1 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Which blood thinner is safest for ICU patients with kidney failure? large study aims to find out
Knowledge-focused Not yet recruitingThis study looks at ICU patients with kidney failure who need blood thinners to prevent dangerous clots. Doctors currently use different types of heparin, but it's unclear which is safest and works best when kidneys are weak. The study will track over 1,100 patients to compare bl…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Kidney trouble may skew chemo safety test – new study aims to fix that
Knowledge-focused Not yet recruitingThis study looks at whether kidney problems interfere with a common blood test used to check how well patients break down certain chemotherapy drugs (fluoropyrimidines). Researchers will measure DPD enzyme activity in about 742 people with breast or digestive cancer, kidney failu…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:38 UTC